Flagship Pioneering as of June 30, 2022
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 12 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Moderna (MRNA) | 69.4 | $1.8B | 13M | 142.85 | |
Sana Biotechnology (SANA) | 8.3 | $220M | 34M | 6.43 | |
Foghorn Therapeutics (FHTX) | 6.5 | $172M | 13M | 13.60 | |
Evelo Biosciences | 4.0 | $106M | 50M | 2.10 | |
Omega Therapeutics (OMGA) | 3.7 | $98M | 26M | 3.80 | |
Denali Therapeutics (DNLI) | 2.9 | $77M | 2.6M | 29.43 | |
Seres Therapeutics (MCRB) | 1.9 | $49M | 14M | 3.43 | |
Axcella Health Inc equity | 1.4 | $38M | 19M | 2.03 | |
Rubius Therapeutics | 1.2 | $33M | 39M | 0.85 | |
Sigilon Therapeutics | 0.3 | $8.6M | 10M | 0.83 | |
Codiak Biosciences | 0.3 | $7.5M | 2.6M | 2.88 | |
Syros Pharmaceuticals | 0.1 | $2.8M | 2.9M | 0.96 |